Complement Inhibition in Xenotransplantation-Where Should the Complement Cascade be Inhibited?

Area of Science:

• Transplantation immunology
• Gene editing
• Complement biology

Background:

• Clinical xenotransplantation with gene-edited pig organs is emerging.
• Transgenic complement-regulatory proteins and CD40/CD154 blockade are established strategies.
• The role of complement inhibitors in xenotransplantation remains unclear.

Purpose of the Study:

• To evaluate the potential of various complement inhibitors in xenotransplantation.
• To discuss the advantages and disadvantages of different inhibition sites.
• To propose an optimal complement inhibition strategy for xenotransplantation.

Main Methods:

• Review of existing literature on complement cascade and inhibitors.
• Analysis of complement activation pathways (classical, lectin, alternative, terminal).
• Discussion of inhibition at various complement factors (C1, C3, C5, Factor B, Factor D).

Main Results:

• The complement cascade is complex with multiple amplification loops.
• Various complement inhibitors exist, each with pros and cons for xenotransplantation.
• A C3/C3b inhibitor is tentatively suggested as potentially optimal.

Conclusions:

• Complement inhibition is a critical but uncertain factor in xenotransplantation.
• A C3/C3b inhibitor may offer advantages over other targets.
• Prolonged complement inhibition might be necessary for successful xenotransplantation.